Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Shore Capital Reaffirms “Buy” Rating for Craneware (LON:CRW)
Craneware (LON:CRW – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Shore Capital in...
Plug Power (NASDAQ:PLUG) Stock Price Down 3.4% – Here’s Why
Plug Power Inc. (NASDAQ:PLUG – Get Free Report)’s stock price fell 3.4% during trading on Tuesday . The stock traded...
Sixth Street Specialty Lending (NYSE:TSLX) Shares Down 0.3% – What’s Next?
Sixth Street Specialty Lending, Inc. (NYSE:TSLX – Get Free Report) shares were down 0.3% on Tuesday . The stock traded...
CommScope (NASDAQ:COMM) Trading 4.4% Higher – Time to Buy?
CommScope Holding Company, Inc. (NASDAQ:COMM – Get Free Report) shot up 4.4% during trading on Tuesday . The company traded...
Tilray (NASDAQ:TLRY) Stock Price Down 3.2% – What’s Next?
Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price fell 3.2% during mid-day trading on Tuesday . The company traded...
Capstone Companies Reports Resignation of Directors and Appointment of New CEO
Capstone Companies, Inc. (OTCMKTS:CAPC) recently disclosed in an 8-K SEC filing the resignation of directors Jeffrey Postal and George Wolf...